Comparison of the vasoconstrictor effects of the selective 5‐HT1D‐receptor agonist L‐775,606 with the mixed 5‐HT1B/1D‐receptor agonist sumatriptan and 5‐HT in human isolated coronary artery
- 1 February 2000
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 49 (2) , 126-131
- https://doi.org/10.1046/j.1365-2125.2000.00129.x
Abstract
Aims Vasoconstriction in human coronary artery can be mediated via activation of both 5-HT2 and 5-HT1B-receptors. Coronary vasoconstriction is a rare, but potential adverse effect of the antimigraine drug sumatriptan. In order to investigate the receptor population involved we compared the vasoconstrictor effects of sumatriptan (a mixed 5-HT1B/1D-receptor agonist) with those of L-775,606 (a selective 5-HT1D-receptor agonist) and 5-HT (the endogenous ligand) in human isolated coronary arteries. Methods Coronary arteries were obtained from human hearts removed prior to transplant surgery. Several endothelium denuded ring segments (4 mm in length) were obtained from each artery and mounted for isometric tension recording. Each segment was first exposed to 45 mm KCl and then to 5-HT (1 nm-100 μm ). Concentration-effect curves to L-775,606 (1-(3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine) and sumatriptan were then performed in a consecutive and random manner. The response to repeated application of 5-HT was obtained in separate segments. Results Twenty-five segments from seven different coronary arteries were studied. Concentration-effect curves were fitted to the data using nonlinear regression analysis. The maximum contraction for L-775,606 was significantly less than that for sumatriptan with Emax values (% relative to 45 mm KCl=100%) of 30.1±4.22 and 41.5±2.7, respectively. L-775,606 was significantly (30-fold) less potent than sumatriptan in causing contraction compared with sumatriptan (EC50 values were 6.0 μm and 0.2 μm, respectively). For comparison the Emax value for 5-HT was 77.2% and the EC50 value was 0.2 μm. Conclusions The selective 5-HT1D-receptor agonist L-775,606 has less propensity towards vasoconstriction in human isolated coronary artery (endothelium-denuded) than was mixed 5-HT1B/1D-receptor agonist sumatriptan. The contractions produced were at concentrations where L-775,606 would be expected to occupy 5-HT1B-receptors.Keywords
This publication has 24 references indexed in Scilit:
- Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5‐HT1B‐receptorsBritish Journal of Clinical Pharmacology, 1998
- Differential Distribution of 5Ht1D-and 5HT1B-Immunoreactivity within the Human Trigemino-Cerebrovascular System: Implications for the Discovery of New Antimigraine DrugsCephalalgia, 1997
- Selective, Orally Active 5-HT1D Receptor Agonists as Potential Antimigraine AgentsJournal of Medicinal Chemistry, 1997
- Initial human experience with MK-462 (rizatriptan): a novel 5=HTIDagonistPublished by Wiley ,1997
- Initial human experience with MK-462 (rizatriptan): a novel 5=HTIDagonistBritish Journal of Clinical Pharmacology, 1997
- 5‐HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5‐HT and sumatriptan with rizatriptan and L‐741,519British Journal of Clinical Pharmacology, 1996
- Expression of serotonin receptor mRNAs in blood vesselsFEBS Letters, 1995
- Is chest pain after sumatriptan oesophageal in origin?The Lancet, 1994
- Transmural myocardial infarction with sumatriptanThe Lancet, 1993
- Mode of action of the anti-migraine drug sumatriptanTrends in Pharmacological Sciences, 1991